Biggest changeThe following table presents a reconciliation of net loss to Adjusted EBITDA: Year Ended December 31, 2024 2023 Net loss from continuing operations $ (22,593,628 ) $ (7,734,290 ) Interest expense and finance cost, net 661,104 2,645,694 Depreciation & amortization 1,054,995 1,302,384 EBITDA (loss) (20,877,529 ) (3,786,212 ) Bad debt (recovery) expense (84,377 ) (143,774 ) Loss on settlement of debt 8,521,149 - Goodwill and intangible assets impairment 4,720,624 - Stock-based compensation 5,614,921 1,490,903 Adjusted EBITDA (Loss) $ (2,105,212 ) $ (2,439,083 ) Liquidity and Capital Resources For the year ended December 31, 2024, net cash used in operating activities was $4.1 million, compared to net cash used in operating activities of $0.9 million for the corresponding period in 2023.
Biggest changeThe following table presents a reconciliation of net los s to Adjusted EBITDA: Year Ended December 31, (in thousands) 2025 2024 Net loss from continuing operations $ (13,099 ) $ (20,651 ) Interest expense and finance cost, net 123 654 Depreciation & amortization 1,947 591 EBITDA (loss) (11,029 ) (19,406 ) Bad debt (recovery) expense 7 (66 ) Loss on debt extinguishment – 8,506 Goodwill and intangible assets impairment 1,748 4,721 Stock-based compensation 3,701 4,425 Adjusted EBITDA (Loss) $ (5,573 ) $ (1,821 ) Liquidity and Cap ital Resources Operating Activities Net cash used in operating activities was approximately $4.6 million for the year ended December 31, 2025, compared to $4.1 million for the year ended December 31, 2024. 23 For the year ended December 31, 2025 the Company reported a net loss from continuing operations of $13.1 million and net loss from discontinued operations of $1.9 million.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK Not applicable. ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA See Index to Consolidated Financial Statements on page F-1 of this Annual Report. ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE None.
The Company is currently evaluating the impact of this standard. ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK Not applicable. ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA See Index to Consolidated Financial Statements on page F-1 of this Annual Report. ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE None.
Critical Accounting Policies, Estimates and Recent Accounting Pronouncements Critical Accounting Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.
Critical Accounting Policies, Estimates and Recent Accounting Pronouncements The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported revenues and expenses.
For the year ended December 31, 2024, net cash provided by investing activities was $1.8 million and $0, respectively. The principal factor was proceeds from a sale of assets for $1.8 million. For the year ended December 31, 2024, net cash provided by financing activities was $3.9 million.
Investing Activities Net cash used in investing activities was approximately $400 thousand for the year ended December 31, 2025, compared to net cash provided by investing activities of $1.8 million for the year ended December 31, 2024. The 2024 cash inflow primarily related to proceeds from the sale of assets.
For the year ended December 31, 2024, the Company recorded a non-cash goodwill impairment charge of $4.7 million, which is included in the consolidated statements of operations for the year ended December 31, 2024. No such impairment was recorded for the year ended December 31, 2024.
Impairment Expense For the year ended December 31, 2025, the Company recorded a non-cash goodwill impairment charge of approximately $1.7 million, compared to $4.7 million for the year ended December 31, 2024. The decrease in impairment expense during 2025 was primarily attributable to the substantial impairment of goodwill recognized in 2024.
For the year ended December 31, 2024, our general and administrative expenses were $8.9 million, including $5.6 million of non-cash stock-based compensation. In 2023, for the corresponding period, our general and administrative expenses were $6.1 million, including $1.5 million of non-cash stock-based compensation.
General and administrative expenses was approximately $7.2 million for the year ended December 31, 2025, including $3.7 million of non-cash stock-based compensation, compared to $7.0 million for the year ended December 31, 2024, including $4.4 million of non-cash stock-based compensation.
Other Income (Expense) Other income (expense) for the year ended December 31, 2024, was expense of $7.6 million compared to income of $2 thousand in the corresponding 2023 period. The primary reason for the loss in 2024 was due to a loss on debt settlement of $8.5 million.
Other Expense Other expense for the year ended December 31, 2025 was approximately $1.3 million, primarily attributable to a $1.2 million change in the fair value of contingent consideration. 22 This compares to other expenses of approximately $7.6 million for the year ended December 31, 2024, which was primarily driven by of a loss on debt extinguishment of 8.5 million.
Net Income (Loss) For the year ended December 31, 2024, we had a net loss from continuing operations of $22.6 million compared to a net loss of $7.7 million during the corresponding year in 2023.
The 2024 loss was partially offset by a gain on assets sale of approximately $1.8 million. Net Income (Loss) For the year ended December 31, 2025, the Company reported a net loss from continuing operations of approximately $13.1 million, compared to a net loss from continuing operations of approximately $20.7 million for the year ended December 31, 2024.
This decrease was primarily attributable to a $358 thousand decrease in hosting and data expenses during the period. Amortization of Intangibles and Impairment Expense For the year ended December 31, 2024, we incurred a non-cash amortization charge of $1.0 million as compared to $1.3 million for the corresponding period in 2023.
The decrease of $1.2 million was primarily attributable to a $3.0 million reduction in impairment expense, partially offset by a $1.4 million increase in amortization of intangible assets. Sales and Marketing Sales and marketing expense was approximately $0.6 million for the year ended December 31, 2025, compared to $0.7 million for the year ended December 31, 2024.
For the year ended December 31, 2024, net loss was $22.6 million.
Results of Operations Year Ended December 31, 2025 Compared to Year Ended December 31, 2024 Revenue Revenue was approximately $97.9 million for the year ended December 31, 2025 compared to $6 thousand for the year ended December 31, 2024.
The amortization expense in 2024 and 2023 relates to the intangible assets acquired from Genesys (now our Recruiting Solutions division), Scouted, Upsider, OneWire, Parrut Novo Group, and GOLQ in 2024.
The increase in amortization expense during 2025 was primarily attributable to intangible assets acquired in connection with the Company’s 2025 telecommunications-related acquisitions, as well as the GOLQ technology license acquired in 2024. Amortization expense in 2024 primarily related to intangible assets acquired in prior acquisitions, including Scouted, Upsider, OneWire, Novo Group, and GOLQ.
The principal factor was issuance of common stock for $4.3 million which was partially offset by repayment of notes payable for $1.0 million. In 2023, net cash provided by financing activities was $1.0 million.
The primary sources of financing were: · $1.8 million from the issuance of common stock · $775 thousand from proceeds under a line of credit For the year ended December 31, 2024, net cash provided by financing activities was approximately $3.9 million, primarily attributable to: · $4.3 million from issuance of common stock · $599 thousand from exercised warrants These inflows were partially offset by $1.1 million in note repayments.
General and Administrative General and administrative expense for the year ended December 31, 2024, includes compensation-related costs for our employees dedicated to general and administrative activities, legal fees, audit and tax fees, consultants and professional services, and general corporate expenses.
General and Administrative General and administrative expenses consist primarily of compensation-related costs for personnel performing corporate, finance, and administrative functions, as well as legal, audit, tax, consulting, and other professional fees and general corporate expenses.